Novartis halts distribution of its Zantac versions amid probe into impurities

8:29am PDT - September 18th, 2019    zantac - Reuters

Novartis AG's Sandoz unit said on Wednesday it was halting distribution of its versions of the drug commonly known as Zantac in all its markets, including the United States and Canada, after contaminants were found in the heartburn drug.